Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CX
CX logo

CX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cemex SAB de CV (CX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
12.000
1 Day change
0.25%
52 Week Range
13.350
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Cemex SAB de CV (CX) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has positive analyst sentiment and potential for upside, the lack of recent AI or SwingMax trading signals, weak financial performance in the latest quarter, and neutral trading trends suggest waiting for a clearer entry point.

Technical Analysis

The technical indicators show mixed signals. The MACD is positive but contracting, RSI is neutral at 52.066, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot point of 11.658, with key resistance at 12.14 and support at 11.177. However, the pre-market and regular market price changes (-0.42% and -1.77%, respectively) indicate short-term weakness.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
10

Positive Catalysts

  • Analyst upgrades with price targets around $14-$15, citing governance improvements, margin protection, and a stronger balance sheet. The stock is also expected to recover from recent selloffs.

Neutral/Negative Catalysts

  • Weak financial performance in Q4 2025, with a significant drop in net income (-835.93% YoY) and negative EPS (-0.02). No recent news or significant trading trends from hedge funds, insiders, or Congress.

Financial Performance

In Q4 2025, revenue increased by 9.66% YoY, and gross margin improved slightly to 32.6%. However, net income dropped significantly (-835.93% YoY), and EPS remained negative at -0.02, indicating financial challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are generally positive, with several upgrades to Outperform or Overweight and price targets ranging from $13.90 to $15. However, one downgrade to Hold suggests some caution due to valuation concerns.

Wall Street analysts forecast CX stock price to rise
6 Analyst Rating
Wall Street analysts forecast CX stock price to rise
3 Buy
3 Hold
0 Sell
Moderate Buy
Current: 11.970
sliders
Low
11.25
Averages
13.18
High
15
Current: 11.970
sliders
Low
11.25
Averages
13.18
High
15
Scotiabank
Outperform
maintain
AI Analysis
2026-04-10
Reason
Scotiabank
Price Target
AI Analysis
2026-04-10
maintain
Outperform
Reason
Scotiabank raised the firm's price target on Cemex to $14.10 from $13.90 and keeps an Outperform rating on the shares. Cemex is "likely to continue to re-rate, regardless of the energy-related headwinds it faces," given the governance changes, which are the "most important structural changes," the analyst tells investors.
Morgan Stanley
Equal Weight -> Overweight
upgrade
$14
2026-03-22
Reason
Morgan Stanley
Price Target
$14
2026-03-22
upgrade
Equal Weight -> Overweight
Reason
Morgan Stanley upgraded Cemex to Overweight from Equal Weight with an unchanged $14 price target. The company is ahead of the curve on margin protection, entering this period from a materially stronger starting point than in 2022, the analyst tells investors in a research note. Cemex's stronger balance sheet, also skews risk-reward on the stock decisively to the upside, the firm added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CX
Unlock Now

People Also Watch